Seborrheic dermatitis
AK Gupta,
R Bluhm,
AK Gupta
Division of Dermatology, Department of Medicine, Sunnybrook and Women's College Health Science Center (Sunnybrook site) and the University of Toronto, Toronto, Canada, and
Mediprobe Laboratories Inc., London, Ontario, Canada.
Corresponding author, Suite 6, 490 Wonderland Road South, London, Ontario, Canada N6K 1L6, Tel. (519) 657 4222; Fax (519) 657 4233; E-mail: [email protected]
Search for more papers by this authorAK Gupta,
R Bluhm,
AK Gupta
Division of Dermatology, Department of Medicine, Sunnybrook and Women's College Health Science Center (Sunnybrook site) and the University of Toronto, Toronto, Canada, and
Mediprobe Laboratories Inc., London, Ontario, Canada.
Corresponding author, Suite 6, 490 Wonderland Road South, London, Ontario, Canada N6K 1L6, Tel. (519) 657 4222; Fax (519) 657 4233; E-mail: [email protected]
Search for more papers by this authorABSTRACT
Seborrheic dermatitis is a common inflammation of the skin, occurring most often on the face, scalp and chest. It is closely related to infantile seborrheic dermatitis, or diaper rash. Seborrheic dermatitis is particularly common in patients with Parkinson's disease or with HIV/AIDS. The recent resurgence of interest in Malassezia yeasts has revived the old hypothesis that seborrheic dermatitis is caused by an altered relationship between these skin commensals and the host. Moreover, the success of antifungal medications in treating seborrheic dermatitis provides new evidence for this view.
Learning objective Upon completing this paper, the reader should be aware of the clinical presentation of seborrheic dermatitis and which populations are at particular risk of developing this disorder. In addition, s/he will be aware of the role of Malassezia yeasts in seborrheic dermatitis and the way in which knowledge of the importance of these yeasts has altered the treatment of this disorder.
References
- 1 Burton JJ, Pye RJ. Seborrhoea is not a feature of seborrheic dermatitis. Br Med J (Clin Res Ed) 1983; 286: 1169–1170.
- 2 Christiansen JV. The paradox of seborrheic dermatitis: a man, a mind and a myth. Acta Derm Venereol (Suppl.) (Stockh) 1985; 120: 90–92.
- 3 Piérard-Franchimont C, Hermanns J, Degreef H et al. From axioms to new insights into dandruff. Dermatology 2000; 200: 93–98.
- 4 Priestly GC, Savin JA. The microbiology of dandruff. Br J Dermatol 1976; 94: 469–470.
- 5 Kligman AM, McGinley KJ, Leyden JJ. The nature of dandruff. J Soc Cosmetic Chem 1976; 27: 111–139.
- 6 Bulmer AC, Bulmer GS. The antifungal action of dandruff shampoos. Mycopathologica 1999; 147: 63–65.
- 7 McGrath J, Murphy GM. The control of seborrheic dermatitis and dandruff by antipityrosporal drugs. Drugs 1991; 41: 178–184.
- 8 Berg M. Epidemiological studies of the influence of sunlight on the skin. Photodermatology 1989; 6: 80–84.
- 9 Yegner E. Seborrhoeic dermatitis of the face induced by PUVA treatment. Acta Derm Venereol (Stockh) 1983; 63: 335–339.
- 10 Kligman AM. Perspectives and problems in cutaneous gerontology. J Invest Dermatol 1979; 73: 39–46.
- 11 Lynch PJ. Dermatologic problems of the head and neck in the aged. Otolaryngol Clin North Am 1982; 15: 271–285.
- 12 Halder RM. Hair and scalp disorders in blacks. Cutis 1983; 32: 378–380.
- 13
Kenney JA Jr.
Dermatoses seen in American Negroes.
Int J Dermatol
1970; 70: 110–113.
10.1111/j.1365-4362.1970.tb04588.x Google Scholar
- 14 Halder RM, Grimes PE, McLaurin CI et al. Incidence of common dermatoses in a predominantly black dermatologic practice. Cutis 1983; 32: 388–390.
- 15 Ostlere LS, Taylor CR, Harris DW et al. Skin surface lipids in HIV-positive patients with and without seborrheic dermatitis. Int J Dermatol 1996; 35: 276–279.
- 16 Hale EK, Bystryn JC. Relation between skin temperature and location of facial lesions in seborrheic dermatitis [letter]. Arch Dermatol 2000; 136: 559–600.
- 17 Bergbrant I-M, Johansson S, Robbins D et al. An immunological study in patients with seborrhoeic dermatitis. Clin Exp Dermatol 1991; 16: 331–338.
- 18 Lifson AR, Hessol NO, Buchbinder SP et al. The association of clinical conditions and serologic tests with CD4+ lymphocyte counts in HIV-infected subjects without AIDS. AIDS 1991; 5: 1209–1215.
- 19
Oranje AP,
Van Joost T,
Van Reede EC et al.
Infantile seborrheic dermatitis. Morphological and immunological study.
Dermatologica
1986; 171: 191–195.
10.1159/000249333 Google Scholar
- 20 Brenner S, Horwitz C. Possible nutrient mediators in psoriasis and seborrheic dermatitis. II. Nutrient mediators; essential fatty acids; vitamins A, E and D; vitamins B1, B2, B6, niacin and biotin; vitamin C; selenium; zinc; iron. World Rev Nutr Diet 1988; 55: 165–182.
- 21
Brenner S,
Horwitz C.
Possible nutrient mediators in psoriasis and seborrheic dermatitis. I. Prevalence, etiology, symptomatology, histological and biochemical features.
World Rev Nutr Diet
1988; 22: 153–164.
10.1159/000415561 Google Scholar
- 22 Pekarek RS, Sandstead HH, Jacob RA et al. Abnormal cellular immune responses during acquired zinc deficiency. Am J Clin Nutr 1979; 32: 1466–1471.
- 23 Balnave D. Clinical symptoms of biotin deficiency in animals. Am J Clin Nutr 1977; 30: 1408–1413.
- 24 Wahlberg JE, Liden C. Is the skin affected by work at visual display terminals? Dermatol Clin 1988; 6: 81–85.
- 25 Lidén C, Wahlberg JE. Work with video display terminals among office employees. V. Dermatologic factors. Scand J Work Environ Health 1985; 11: 489–493.
- 26 Rosset M, Oki G. Skin diseases in alcoholics. O J Stud Alcohol 1971; 32: 1017–1024.
- 27 Shellow WV. The skin in alcoholism. Int J Dermatol 1983; 22: 506–510.
- 28 Maietta G, Rongioletti F, Rebora A. Seborrheic dermatitis and daylight [letter]. Acta Derm Venereol 1993; 73: 396.
- 29 Barba A, Piubello W, Vantini I et al. Skin lesions in chronic alcoholic pancreatitis. Dermatologica 1982; 164: 322–326.
- 30 Maietta G, Fornaro P, Rongioletti F et al. Patients with mood depression have a high prevalence of seborrhoeic dermatitis. Acta Derm Venereol 1990; 70: 432–434.
- 31 Barbeau A. Dopamine and disease. Can Med Assoc J 1970; 103: 824–832.
- 32 Binder RL, Jonelis FJ. Seborrheic dermatitis in neuroleptic-induced Parkinsonism. Arch Dermatol 1983; 119: 473–475.
- 33 Marino CT, McDonald E, Romano JF. Seborrheic dermatitis in acquired immunodeficiency syndrome. Cutis 1991; 50: 217–218.
- 34 Mathes BM, Douglass MC. Seborrheic dermatitis in patients with acquired immunodeficiency syndrome. J Am Acad Dermatol 1985; 13: 947–951.
- 35 Cribier B, Samain F, Vetter D et al. Systematic cutaneous examination in hepatitis C virus infected patients. Acta Derm Venereol 1992; 72: 454–455.
- 36 Clift DC, Dodd JH, Kirby JD et al. Seborrheic dermatitis and malignancy. An investigation of the skin flora. Acta Derm Venereol 1988; 68: 48–52.
- 37 Ercis M, Balci S, Atakan N. Dermatological manifestations of 71 Down syndrome children admitted to a clinical genetics unit. Clin Genet 1996; 50: 317–320.
- 38 Marren P, Burge S. Seborrhoeic dermatitis of the scalp – a manifestation of Hailey−Hailey disease in a predisposed individual? Br J Dermatol 1992; 126: 294–296.
- 39 Gross-Tsur V, Gross-Kieselstein E, Amir N. Cardio–facio cutaneous syndrome: neurological manifestations. Clin Genet 1990; 38: 382–386.
- 40 Saboraud R. Maladies Desquamataities. Paris, 1904.
- 41 MacKee GM, Lewis GM. Dandruff and seborrhea I. Flora of normal and diseased scalps. J Invest Dermatol 1938; 1: 31.
- 42 Bergbrant I-M, Faergemann J. Seborrhoeic dermatitis and Pityrosporum ovale: a cultural and immunological study. Acta Derm Venereol (Stockh) 1989; 69: 332–335.
- 43 McGinley KJ, Leyden JJ, Marples RR et al. Quantitative microbiology of the scalp in non-dandruff, dandruff and seborrhoeic dermatitis. J Invest Dermatol 1975; 64: 401–405.
- 44 Heng MCY, Henderson CL, Barker DC et al. Correlation of Pityrosporum ovale density with clinical severity of sebhorrheic dermatitis as assessed by a simplified technique. J Am Acad Dermatol 1990; 23: 82 – 86.
- 45 Leyden JJ, McGinley JK, Kligman AM. Role of microorganisms in dandruff. Arch Dermatol 1976; 112: 333– 338.
- 46 Ford GP, Farr PM, Ive FA et al. The response of seborrheic dermatitis to ketoconazole. Br J Derm 1984; 111: 603 – 609.
- 47 Ortonne J-P, Lacour J-P, Vitetta A et al. Comparative study of ketoconazole 2% foaming gel and betamethasone dipropionate 0.05% lotion in the treatment of seborrheic dermatitis in adults. Dermatology 1992; 184: 275– 280.
- 48 Guého E, Midgley G, Guillot J. The genus Malassezia with description of four new species. Antonie Van Leeuwenhoek 1996; 69: 337 – 355.
- 49 Gupta AK, Kohli Y, Summerbell RC et al. Quantitative culture of Malassezia species from different body sites of individuals with or without dermatoses. Med Mycol 2001; 39: 243 – 251.
- 50 Nakabayashi A, Sei Y, Guillot J. Identification of Malassezia species isolated from patients with seborrhoeic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects. Med Mycol 2000; 38: 337 – 341.
- 51 Sandström MH, Bartosik J, Bäck O et al. The prevalence of the Malassezia yeasts in patients with atopic dermatitis, seborrheic dermatitis and healthy controls [abstract]. JEADV 2001; 15 (Suppl. 2): 104 – 274 .
- 52 Cowley NC, Farr PM. A dose–response study of irritant reactions to sodium lauryl sulphate in patients with seborrhoeic dermatitis and atopic eczema. Acta Derm Venereol (Stockh) 1992; 72: 432 – 435.
- 53 Sudan BJL. Seborrheic dermatitis induced by nicotine of horsetails (Equisetum arvense L.). Contact Dermatitis 1985; 13: 201–202.
- 54 Sudan BL, Brouillard C, Sterboul J et al. Nicotine as a hapten in seborrheic dermatitis. Contact Dermatitis 1984; 11: 196–197.
- 55 Midgley G, Hay RJ. Serological responses to Pityrosporum (Malassezia) in seborrhoeic dermatitis demonstrated by ELISA and Western blotting. Bull Soc Fr Med Mycol 1988; 17: 267–276.
- 56 Parry ME, Sharpe GR. Seborrhoeic dermatitis is not caused by an altered immune response to Malassezia yeast. Br J Dermatol 1998; 139: 254–263.
- 57 Faergemann J, Bergbrant I-M, Dohsé M. Seborrhoeic dermatitis and Pityrosporum (Malassezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunohistochemistry. Br J Dermatol 2001; 144: 549–556.
- 58 Gupta AK. A random survey concerning aspects of acne rosacea [abstract]. J Cut Med Surg 2001; 5 (Suppl.): 38.
- 59 Zug KA, Palay DA, Rock B. Dermatologic diagnosis and treatment of itchy red eyelids. Surv Ophthalmol 1996; 40: 293–306.
- 60 McCulley JP, Dougherty JM. Blepharitis associated with acne rosacea and seborrheic dermatitis. Int Ophthalmol Clin 1985; 25: 159–172.
- 61 McCulley JP, Dougherty JM, Deneeau DG. Classification of chronic blepharitis. Ophthalmology 1982; 89: 1173–1180.
- 62 Reisner RM. Acne vulgaris. Pediatr Clin N Am 1973; 20: 851–864.
- 63 Sunenshine PJ, Schwartz RA, Janniger CK. Tinea versicolor: an update. Cutis 1998; 61: 65–72.
- 64 Faergemann J, Johansson S, Bäck O. An immunologic and cultural study of Pityrosporum folliculitis. J Am Acad Dermatol 1986; 14: 429–433.
- 65 Ackerman AB. Histopathologic differentiation of eczematous dermatitis from psoriasis and seborrheic dermatitis. Cutis 1977; 20: 619–623.
- 66
Civatte A.
Psoriasis and seborrheic eczema: pathological anatomy and diagnostic histology of the two dermatoses.
Br J Derm Syph
1924; 36: 461.
10.1111/j.1365-2133.1924.tb09144.x Google Scholar
- 67 Pinkus H, Mehregan AH. The primary histologic lesion of seborrheic dermatitis and psoriasis. J Invest Derm 1966; 46: 109–116.
- 68 Leyden JJ. Diaper dermatitis. Dermatol Clin 1986; 4: 23–28.
- 69 Leung AK. Neonatal seborrheic dermatitis [letter]. West J Med 1985; 142: 558.
- 70 Yates VM, Kerr RE, MacKie RM. Early diagnosis of infantile seborrhoeic dermatitis and atopic dermatitis – clinical features. Br J Dermatol 1983; 108: 633–638.
- 71 Vickers CFH. The natural history of atopic eczema. Acta Dermato-Venereol Suppl 1980; 92: 113.
- 72 Podmore P, Burrows D, Eedy DJ et al. Seborrhoeic eczema – a disease entity or a clinical variant of atopic eczema? Br J Dermatol 1986; 115: 341–350.
- 73 Clemmenson OJ, Hjorth N. Treatment of atopic dermatitis of the head and neck with ketoconazole in patients with type I sensitivity to Pityrosporum orbiculare. Semin Dermatol 1983; 2: 26–29.
- 74 Broberg A, Faergemann J. Infantile seborrheic dermatitis and Pityrosporum ovale. Br J Dermatol 1989; 120: 359–362.
- 75 Tollesson A, Frithz A, Stenlund K. Malassezia furfur in infantile seborrheic dermatitis. Pediatr Dermatol 1997; 14: 423–425.
- 76 Ruiz-Maldonado R, Lopez-Matinez R, Perez Chavarria EL, Rocio Castanon L, Tamayo L. Pityrosporum ovale in infantile seborrheic dermatitis. Pediatr Dermatol 1989; 6: 16–20.
- 77 Andersen SL, Thomsen K. Psoriasiform napkin dermatitis. Br J Dermatol 1971; 84: 316–319.
- 78 Neville EA, Finn OA. Psoriasiform napkin dermatitis – a follow-up study. Br J Dermatol 1975; 92: 279–285.
- 79 Ilchyshyn A, Meldelsohn SS, Macfarlane A et al. Candida albicans and infantile seborrhoeic dermatitis. Br J Clin Pract 1987; 41: 557–559.
- 80 Leyden JJ, Kligman AM. The role of microorganisms in diaper dermatitis. Arch Dermatol 1978; 114: 56–59.
- 81
Leiner C.
Uber Erythrodermia desquamativa, eine eingenartige universelle Dermatose der Brustkinder.
Arch Dermatol Syphilol
1908; 89: 163–189.
10.1007/BF01829919 Google Scholar
- 82 Odom RB, James WB, Berger TG. Andrew's Diseases of the Skin, 9th edn. Philadelphia, PA: W.B. Saunders, 2000.
- 83 Friedlander SF, West A, Eichenfield LF. Isolated leukemia cutis presenting as ‘seborrheic dermatitis’. Clin Pediatr 1996; 35: 531–534.
- 84 Henderson CA, Taylor J, Cunliffe WJ. Sebum excretion rates in mothers and neonates. Br J Dermatol 2000; 142: 110–111.
- 85 Tollesson A, Frithz A, Berg A et al. Essential fatty acids in infantile seborrheic dermatitis. J Am Acad Dermatol 1993; 28: 957–961.
- 86 Nisenson A, Barness LA. Treatment of seborrheic dermatitis with biotin and vitamin B complex. J Pediatr 1972; 8: 630–631.
- 87 Kalayci O, Coskun T, Tokatli A et al. Infantile spasms as the initial symptom of biotinidase deficiency. J Pediatr 1994; 124: 103–103.
- 88 Erlichman M, Goldstein R, Levi E et al. Infantile flexural seborrhoeic dermatitis. Neither biotin nor essential fatty acid deficiency. Arch Dis Child 1981; 56: 560–562.
- 89 Podmore P, Burrows D, Eedy D. T-cell subset assay. A useful differentiating marker of atopic and seborrheic eczema in infancy? Arch Dermatol 1988; 124: 1235–1238.
- 90 Yates VM, Kerr RE, Frier K et al. Early diagnosis of infantile seborrhoeic dermatitis and atopic dermatitis – total and specific IgE levels. Br J Dermatol 1983; 108: 639–645.
- 91 Nisenson A. Seborrheic dermatitis of infants: treatment with biotin injections for the nursing mother. Pediatrics 1969; 18: 211–217.
- 92 Keipert JA. Oral use of biotin in seborrhoeic dermatitis of infancy: a controlled trial. Med J Aust 1976; 1: 584–585.
- 93 Tollesson A, Frithz A. Borage oil, an effective new treatment for infantile seborrhoeic dermatitis [letter]. Br J Dermatol 1993; 129: 95.
- 94 Turpeinen M. Influence of age and severity of dermatitis on the percutaneous absorption of hydrocortisone in children. Br J Dermatol 1988; 118: 517–522.
- 95 Rogers SC, Burrows D, Neill D. Percutaneous absorption of phenol and methyl alcohol in Magenta Paint B.P.C. Br J Dermatol 1978; 98: 559–560.
- 96 Shohat M, Mimouni M, Varsano I. Efficacy of topical application of glucocorticosteroids compared with eosin in infants with seborrheic dermatitis. Cutis 1987; 40: 67–68.
- 97 Shohat M, Mimouni M, Shuper A et al. Adrenocortical suppression by topical application of glucocorticosteroids in infants with seborrheic dermatitis. Clin Pediatr 1986; 25: 209–212.
- 98 Keipert JA, Kelly R. Temporary Cushing's syndrome from percutaneous absorption of betamethasone 17-valerate. Med J Aust 1971; 1: 542–544.
- 99 Turpeinen M, Salo OP, Leisti S. Effect of percutaneous absorption of hydrocortisone on adrenocortical responsiveness in infants with severe skin disease. Br J Dermatol 1986; 115: 475–484.
- 100 Taieb A, Legrain V, Palmier C et al. Topical ketoconazole for infantile seborrhoeic dermatitis. Dermatologica 1990; 181: 26–32.
- 101 Berger S, Stoner MF, Hobbs ER et al. Cutaneous manifestations of early human immunodeficiency virus exposure. J Am Acad Dermatol 1988; 19: 298–303.
- 102 Barton JC, Buchness MR. Nongenital dermatologic disease in HIV-infected women. J Am Acad Dermatol 1999; 40: 938–948.
- 103 Prose N. HIV infection in children. J Am Acad Dermatol 1990; 22: 1223–1231.
- 104 Mahe A, Boulais C, Blanc L et al. Seborrheic dermatitis as a revealing feature of HIV infection in Bamako, Mali [letter]. Int J Dermatol 1994; 33: 601–602.
- 105 Mahe A, Simon F, Coulibaly S. Predictive value of seborrheic dermatitis and other common dermatoses for HIV infection in Bamako, Mali. J Am Acad Dermatol 1998; 38: 1084–1086.
- 106 Eisenstat BA, Wormser GP. Seborrheic dematitis and butterfly rash in AIDS [letter]. N Engl J Med 1984; 311: 189.
- 107 Soeprono FF, Schinella RA, Cockerell CJ et al. Seborrheic-like dermatitis of acquired immunodeficiency syndrome. A clinicopathologic study. J Am Acad Dermatol 1986; 14 (2 Part 1): 242–248.
- 108 Alessi E, Cusini M, Zerboni R. Mucocutaneous manifestations in patients infected with human immunodeficiency virus. J Am Acad Dermatol 1988; 19 (2 Part 1): 290–297.
- 109 Matis WL, Triana A, Shapiro R et al. Dermatologic findings associated with human immunodeficiency virus infection. J Am Acad Dermatol 1987; 17: 46–51.
- 110 Senaldi G, Di Perri G, Di Silverio A et al. Seborrhoeic dermatitis: an early manifestation in AIDS [letter]. Clin Exp Dermatol 1987; 12: 72–73.
- 111 Vidal C, Girard PM, Dompmartin D et al. Seborrheic dermatitis and HIV infection. Qualitative analysis of skin surface lipids in men seropositive and seronegative for HIV. J Am Acad Dermatol 1990; 23 (6 Part 1): 1106–1110.
- 112 Puig L, Fernandez-Figueras T, Ferrandiz C et al. Epidermal expression of 65 and 72 kD heat shock proteins in psoriasis and AIDS-associated psoriasiform dermatitis. J Am Acad Dermatol 1995; 33: 985–989.
- 113 Skinner RB, Zanolli MD, Noah PW et al. Seborrheic dermatitis and acquired immunodeficiency syndrome [letter]. J Am Acad Dermatol 1986; 14: 147–148.
- 114 Wikler JR, Nieboer C, Willemze R. Quantitative skin cultures of Pityrosporum yeasts in patients seropositive for the human immunodeficiency virus with and without seborrheic dermatitis. J Am Acad Dermatol 1992; 27: 37–39.
- 115 Buchness MR. Treatment of skin diseases in HIV-infected patients. Dermatol Clin 1995; 13: 231–238.
- 116 Coldiron BM, Bergstresser PR. Prevalence and clinical spectrum of skin disease in patients infected with human immunodeficiency virus. Arch Dermatol 1989; 125: 357–361.
- 117 Goodman DS, Teplitz ED, Wishner A et al. Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. J Am Acad Dermatol 1987; 17: 210–220.
- 118 Dann FJ, Tabibian P. Cutaneous diseases in human immunodeficiency virus-infected patients referred to the UCLA Immunosuppression Skin Clinic: reasons for referral and management of select diseases. Cutis 1995; 55: 85–88.
- 119 Cohn T. Encephalitis ohne Lethargie wahrend der Grippe epidemie. Zentralblatt Neurochiurgie 1920; 39: 260.
- 120
Krfstin D.
The seborrhoeic facies as a manifestation of postencephalitic Parkinsonism and allied disorders.
Q J Med
1927; 21: 177.
10.1093/qjmed/os-21.81.177 Google Scholar
- 121 Burton JL, Cartlidge M, Cartlidge NEF, Shuster S. Sebum excretion in Parkinsonism. Br J Dermatol 1973; 88: 263–266.
- 122 Cowley NC, Farr RM, Shuster S. The permissive effect of sebum in seborrhoeic dermatitis: an explanation of the rash in neurological disorders. Br J Dermatol 1990; 122: 71–76.
- 123 Burton JL, Shuster S. Effect of L-Dopa on seborrhœa of Parkinsonism. Lancet 1970; 2(7662): 19–20.
- 124 Martignoni E, Godi L, Pacchetti C et al. Is seborrhea a sign of autonomic impairment in Parkinson's disease? J Neural Transm 1997; 104: 1295–1304.
- 125 Shuster S, Thody AJ, Goolamali SK et al. Melanocyte-stimulating hormone and Parkinsonism. Lancet 1973; 1(7801): 463–464.
- 126 Burton JL, Cartlidge M, Shuster S. Effect of L-Dopa on the seborrhoea of Parkinsonism. Br J Dermatol 1973; 88: 475–479.
- 127 Sandyk R, Pardeshi R. Topographic subtypes of tardive dyskinesia: relationship to seborrhea [letter]. Intern J Neuroscience 1990; 54: 321–323.
- 128 Sandyk R. Seborrhea and persistent tardive dyskinesia. Intern J Neurosci 1990; 50: 223–236.
- 129 Sandyk R, Kay SR. The relationship of negative schizophrenia to Parkinsonism. Intern J Neurosci 1990; 55: 1–59.
- 130 Christodoulou GN, Vareltzides AG. Positive side effects of lithium? [letter]. Am J Psychiatry 1978; 135: 10.
- 131 Christodoulou GN, Georgala S, Vareltzides A et al. Lithium in seborrheic dermatitis. Psychiatr J University Ott 1983; 8: 27–29.
- 132 Yung CY. A review of clinical trials of lithium in medicine. Pharmacol Biochem Behav 1984; 21 (Suppl. 1): 51–54.
- 133 Peter RU, Richarz-Barthauer U. Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial. Br J Dermatol 1995; 132: 441–445.
- 134 Lin AN, Reimer RJ, Carter DM. Sulfur revisited. J Am Acad Dermatol 1998; 18: 553–558.
- 135 Orentreich N, Taylor EH, Berger RA et al. Comparative study of two antidandruff preparations. J Pharm Sci 1969; 58: 1279–1280.
- 136 Fredriksson T. Controlled comparison of Clinitar shampoo and Selsun shampoo in the treatment of seborrheic dermatitis. Br J Clin Pract 1985; 39: 25–28.
- 137 Olansky S. Whole coal tar shampoo: a therapeutic hair repair system. Cutis 1980; 25: 99–104.
- 138 Garcia RL, Miller JD, Miller JN. Occlusive tar extract therapy for recalcitrant psoriasis and seborrheic dermatitis of the scalp. Cutis 1978; 22: 90–91.
- 139 Gould DJ, Mortimer PS, Proby C et al. A double-blind, placebo-controlled, multicenter trial of lithium succinate ointment in the treatment of seborrheic dermatitis. J Am Acad Dermatol 1992; 26: 452–457.
- 140 Culelenaere C, De Bersaques J, Kint A. Use of topical lithium succinate in the treatment of seborrhoeic dermatitis. Dermatology 1992; 184: 194–197.
- 141 Langtry JAA, Rowland Payne CME, Staughton RDC et al. Topical lithium succinate ointment (Efalith) in the treatment of AIDS-related seborrheic dermatitis. Clin Exp Dermatol 1997; 22: 216–219.
- 142 Leeming JP, Burton JL. Lithium succinate and seborrhoeic dermatitis: an antifungal mode of action? [letter]. Br J Derm 1990; 122: 718–719.
- 143 Boyle J, Burton JL, Faergemann J. Use of topical lithium succinate for seborrheic dermatitis. Br Med J 1986; 292: 28.
- 144 Bonnetblanc JM, Bernard P. Benzoyl peroxide in seborrheic dermatitis. Arch Dermatol 1986; 122: 752.
- 145 Faergemann J. Short-term treatment of dandruff with a combination of propylene glycol solution and shampoo. Cutis 1988; 42: 146.
- 146 Christiansen JV, Gadborg E, Kleiter I et al. Efficacy of Bufexamac (NFN) cream in skin diseases: a double-blind, multicentre trial. Dermatologica 1977; 154: 177–184.
- 147 Dahl KB, Reymann F. Photochemotherapy in erythrodermic seborrheic dermatitis [letter]. Arch Dermatol 1977; 113: 1295–1296.
- 148 Lloyd KM. The value of neomycin in topical corticosteroid preparations. South Med J 1969; 62: 94–96.
- 149 Cullen SI. Selective evaluation of a new topical steroid (betamethasone benzoate). Curr Ther Res Clin Exp 1968; 10: 270–275.
- 150 Harris JJ. A national double-blind clinical trial of a new corticosteroid lotion: a 12-investigator cooperative analysis. Curr Ther Res Clin Exp 1972; 14: 638–646.
- 151 Marks R, Bhogal B, Wilson L. The effect of betamethasone valerate on seborrheic dermatitis of the scalp: a clinical, histopathological and cell kinetic study. Acta Derm Venereol (Stockh) 1974; 54: 373–375.
- 152 Rosenberg EW. Fluocinonide: preliminary evaluation of a new topically applied corticosteroid. Arch Derm 1971; 104: 632–633.
- 153 Binder R, McCleary J. Comparison of fluocinonide in a double-blind study with betamethasone valerate. Curr Ther Res Clin Exp 1972; 14: 35–38.
- 154 Leu F. Complications from prolonged topical steroid therapy [letter]. J Am Acad Dermatol 1983; 8: 425–426.
- 155 Nierman MM. Safety and efficacy of clocortolone pivalate 0.1 percent cream in the treatment of atopic dermatitis, contact dermatitis and seborrheic dermatitis. Cutis 1981; 27: 670–671.
- 156 Morman MR. Possible side effects of topical steroids. Am Fam Physician 1981; 23: 171–174.
- 157 Weber G. Rosacea-like dermatitis: contraindication or intolerance reaction to strong steroids. Br J Dermatol 1972; 86: 253–259.
- 158 Johnson BA, Nunley JR. Treatment of seborrheic dermatitis. Am Fam Physician 2000; 61: 2703–2710.
- 159 Guin JD. Complications of topical hydrocortisone. J Am Acad Dermatol 1981; 4: 417–422.
- 160 Brauer EW, Opdyke DL, Burnett CM. The anti-seborrheic qualities of zinc pyrithione (zinc-pyridine-2-thiol-2-oxide) in a cream vehicle. J Invest Dermatol 1966; 47: 174–176.
- 161 Marks R, Pearse AD, Walker AP. The effects of a shampoo containing zinc pyrithione on the control of dandruff. Br J Dermatol 1985; 112: 415–522.
- 162 Opdyke DL, Burnett CM, Brauer EW. Anti-seborrhoeic qualities of zinc pyrithione in a cream vehicle. II. Safety evaluation. Fd Cosmet Toxicol 1967; 5: 321–326.
- 163 Veien NK, Pilgaard CE, Gade M. Seborrhoeic dermatitis of the scalp treated with a tar/zinc pyrithione shampoo. Clin Exp Dermatol 1979; 4: 53–56.
- 164 Segal R, David M, Ingber A. Treatment with bifonazole shampoo for seborrhea and seborrheic dermatitis: a randomized, double-blind study. Acta Derm Venereol (Stockh) 1992; 72: 454–455.
- 165 Shiri J, Amachai B. Treatment of seborrheic dermatitis of the scalp and dandruff with a shampoo containing 1% bifonazole (Agispor shampoo). J Dermatol Treat 1998; 9: 95–96.
- 166 Zienicke H, Korting HC, Braun-Falco O et al. Comparative efficacy and safety of bifonazole 1% cream and the corresponding base preparation in the treatment of seborrheic dermatitis. Mycoses 1993; 36: 325–331.
- 167 Shemer A, Nathanson N, Kaplan B et al. Treatment of scalp seborrheic dermatitis and psoriasis with and ointment of 40% urea and 1% bifonazole. Int J Dermatol 2000; 39: 521–538.
- 168 Faergemann J. Seborrhoeic dermatitis and Pityrosporum orbiculare: treatment of seborrhoeic dermatitis of the scalp with miconazole hydrocortisone (Daktacort), miconazole and hydrocortisone. Br J Dermatol 1986; 114: 695–700.
- 169 Farr PM, Shuster S. Treatment of seborrheic dermatitis with topical ketoconazole [letter]. Lancet 1984, 2(8414): 1271–1272.
- 170 Green CA, Farr PM, Shuster S. Treatment of seborrhoeic dermatitis with ketoconazole. II. Response of seborrheic dermatitis of the face, scalp and trunk to topical ketoconazole. Br J Dermatol 1987; 116: 217–221.
- 171 Peter RU, Korting HC. Behandlung des seborrhoischen Ekzems mit Ketoconazol im Vergleich zu einer Wirkstoff-freien Pflegecreme. Arzneimittelforschung 1991; 41: 852–854.
- 172 Skinner RB, Noah PW, Taylor RM. Double-blind treatment of seborrheic dermatitis with 2% ketoconazole cream. J Am Acad Dermatol 1985; 12: 852–856.
- 173 Carr MM, Pryce DM, Ive FA. Treatment of seborrhoeic dermatitis with ketoconazole. I. Response of seborrhoeic dermatitis of the scalp to topical ketoconazole. Br J Dermatol 1987; 116: 213–216.
- 174 Piérard-Franchimont C, Piérard GE, Arrese JE et al. Effect of ketoconazole 1% and 2% shampoos on severe dandruff and seborrheic dermatitis: clinical, squamometric and mycological assessments. Dermatology 2001; 202: 171–176.
- 175 Dobrev H, Zissova L. Effect of ketoconazole 2% shampoo on scalp sebum level in patients with seborrheic dermatitis. Acta Derm Venereol (Stockh) 1997; 77: 132–134.
- 176 Piérard GE, Piérard-Franchimont C, Van Cutsem J et al. Ketoconazole 2% emulsion in the treatment of seborrheic dermatitis. Int J Dermatol 1991; 30: 806–809.
- 177 Danby FW, Maddin WS, Margesson LJ et al. A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% in the treatment of moderate to severe dandruff. J Am Acad Dermatol 1993; 29: 1008–1012.
- 178 Stratigos JD, Antoniou C, Katsambas A et al. Ketoconazole 2% cream versus hydrocortisone 1% cream in the treatment of seborrheic dermatitis: a double-blind comparative study. J Am Acad Dermatol 1988; 19: 850–853.
- 179 Rigopoulos D, Katsambas A, Antoniou C. Facial seborrheic dermatitis treated with fluconazole 2% shampoo. Int J Dermatol 1994; 33: 136–137.
- 180 Parsad D, Pandhi R, Negi KS et al. Topical metronidazole in seborrheic dermatitis – a double-blind study. Dermatology 2001; 202: 35–37.
- 181 Iudica AC. Does treatment with topical metronidazole improve seborrheic dermatitis? J Fam Pract 2001; 50: 492.
- 182 Anonymous. Treatment of tinea versicolor with a new antifungal agent, ciclopirox olamine cream 1%. Clin Ther 1985; 7: 574–583.
- 183 Hanel H, Smith Kurtz E, Pastowsky S. Therapy of seborrhoeic eczema with an antifungal agent with an antiphlogistic effect. Mycoses 1991; 34 (Suppl. 1): 91–93.
- 184 Vardy DA, Zvulunov A, Tchetov T et al. A double-blind, placebo-controlled trial of ciclopiroxolamine 1% shampoo for treatment of scalp seborrheic dermatitis. J Dermatol Treatment 2000; 11: 73–77.
- 185 Dupuy P, Maurette C, Amoric JC. Randomized, placebo-controlled, double-blind study on clinical efficacy of ciclopiroxolamine 1% cream in facial seborrhoeic dermatitis. Br J Dermatol 2001; 144: 1033–1037.
- 186 Aly R, Katz I, Kempers SE, Lookingbill D et al.Ciclopirox gel for seborrheic dermatitis of the scalp. Int J Dermatol 2003; 42 (Suppl. 1): 19–22.
- 187 Petranyi G, Ryder NS, Stütz A. Allylamine derivatives: a new class of synthetic antifungal agents inhibiting fungal squalene epoxidase. Science 1984; 224: 1239–1241.
- 188 Faergemann J, Jones TC, Hettler O et al. Pityrosporum ovale (Malassezia furfur) as the causative agent of seborrhoeic dermatitis: new treatment options. Br J Dermatol 1996; 134 (Suppl. 46): 12–15.
- 189 Baroni A, De Rosa R, De Rosa A et al. New strategies in dandruff treatment: growth control of Malassezia ovalis. Dermatology 2000; 201: 332–336.
- 190 Al-Waili NS. Therapeutic and prophylactic effects of crude honey on chronic seborrheic dermatitis and dandruff. Eur J Med Res 2001; 30: 306–308.
- 191 Caputo R, Barbareschi M, Gorani A et al. Itraconazole: new horizons [abstract]. JEADV 2001; 15 (Suppl. 2): 93.
- 192 Caputo R, Barbareschi M. Itraconazole: new horizons. Giornale Italiano di dermatological e venereologica 2002; 137: 1–7.
- 193 Villars V, Jones TC. Clinical efficacy and tolerability of terbinafine (Lamisil) – a new topical and systemic fungicidal drug for treatment of dermatomycoses. Clin Exp Dermatol 1989; 14: 124–127.
- 194 Scapparo E, Quadri G, Virno G et al. Evaluation of the efficacy and tolerability of oral terbinafine (Daskil®) in patients with seborrheic dermatitis. A multicentre, randomized, investigator-blinded, placebo-controlled trial. Br J Dermatol 2001; 144: 854–857.
- 195 Cauwenbergh G, Degreef H, Heykants J et al. Pharmacokinetic profile of orally administered itraconazole in human skin. J Am Acad Dermatol 1988; 18: 263–268.
- 196 Faergemann J, Zehnender H, Denouel J et al. Levels of terbinafine in plasma, stratum corneum, dermis−epidermis, sebum, hair and nails during and after 250 mg terbinafine orally once per day for 4 weeks. Acta Derm Venereol (Stockh) 1993; 73: 305–309.
Citing Literature
